NKTR : Analysis & Opinions

  1. New Ratings

    October 9, 2012
    New York, May 23rd (TradersHuddle.com) - These are the research analyst new ratings before the market open. Travelers (NYSE:TRV) ...
  2. The Salix Story Keeps Improving

    January 18, 2012
    Salix is a great candidate for growth investors.
  3. The Curious And Complicated Case Of MannKind

    December 15, 2010
    MannKind is a classic high-risk high-reward biotech story.
  4. There Is Life After Death, At Least In Biotech

    June 22, 2010
    Clinical failure is not the end of the story for all biotechs. How do some survive while others disappear?
Trading Center